Member Log-in

I forgot my password

Not a Member? Register

Earmarking for Health

From theory to practice

This paper discusses the theoretical foundations of earmarking and analyses country experience with earmarking for health and its impact on health sector budgets and the broader fiscal environment.

Many countries are considering earmarking as a mechanism to increase fiscal space and mobilize resources for the health sector, to finance progress toward universal health coverage (UHC), or to fund other health priorities. Earmarking involves separating all or a portion of total revenue – or revenue from a tax or group of taxes – and setting it aside for a designated purpose. Earmarking has become part of the global discussion on domestic resource mobilization for health, particularly as countries transition from donor support and work to achieve health system goals as well as other targets. Earmarking is also increasingly used as an instrument of public health policy – to tax the consumption of unhealthy products such as alcohol and tobacco, for example.

The arguments for and against earmarking are numerous, but they often remain theoretical. Despite vast country experience with this policy instrument – at least 80 countries earmark for health – little empirical evidence has been introduced into the debate. Few studies have examined the characteristics of earmarking policies and which country contexts may be conducive to the beneficial use of earmarking.

This paper discusses the theoretical foundations of earmarking, and it analyses country experience with earmarking for health and its impact on health sector budgets and the broader fiscal environment. The goal is to provide useful information to health and finance authorities, and to the international partners who support them, on the practical realities of designing, adopting and implementing earmarking policies. It is not a quantitative analysis or in-depth study of any particular form of earmarking; rather, it highlights key characteristics of this tool and important factors to consider before deciding whether to implement earmarking for health.

The findings suggest that the results of earmarking for health are highly context-specific and dependent on a country’s political priorities and budget process. In some cases, earmarking has been a tool to advance and sustain a national health priority. In Ghana, Estonia and the Philippines, earmarking for health has made it possible to launch or expand a national health insurance program – and in the case of South Africa, to mobilize an effective domestic response to the HIV/AIDS epidemic.

The findings also suggest, however, that in most cases earmarking is unlikely to bring a significant and sustained increase in the priority placed on health in overall government spending. Budgets are fungible, and earmarking one revenue source is likely to result in offsets through cuts in other sources. Furthermore, earmarking can introduce rigidity into the budget process, and the inefficiencies in some cases can be severe. Earmarking has been more effective when practices come closer to standard budget processes – that is, softer earmarks with broader expenditure purposes and more flexible revenue–expenditure links.

 

You May Also Like

Immunization and the Role of the Private Sector

Abt Associates conducted analyses of the role of the private sector in three different settings – Benin, Georgia, and Malawi. Each analysis resulted in a report containing information on the country’s private sector health services, policy implications, and recommendations for the provision of vaccinations in the private sector. Benin | Georgia | Malawi

The Role of National Immunisation Technical Advisory Groups (NITAGs) in Strengthening National Vaccine Decision-making: A Comparative Case Study of Armenia, Ghana, Indonesia, Nigeria, Senegal and Uganda

Improving evidence informed decision-making in immunization is a global health priority and many low and middle-income countries have established National Immunization Technical Advisory Groups (NITAGs) as independent technical advisory bodies for this purpose. This study examined NITAGs in six low and middle-income countries – Armenia, Ghana, Indonesia, Nigeria, Senegal, and Uganda – to examine functionality, quality of recommendation … Continued

Immunization Financing in MENA Middle-Income Countries

Most Middle East and North Africa (MENA) countries have high immunization coverage rates. But immunization coverage has dropped considerably in some (including Iraq, the Syrian Arab Republic and Yemen), due to the conflicts, instability and the prevailing geopolitical situation in the region. Approximately 1.3 million surviving infants in MENA missed their third dose of DTP … Continued

Choose a Language